Working Group 2 – Mineralocorticoid Receptor Structure and Function

Working Group 2 Members

C Grossman

Research Group 1

Working Group Leader

Head: Professor Claudia Grossman

Julius Bernstein Institute of Physiology

Martin Luther Universitat Halle-Wittenberg, Germany

Keywords: Mineralocorticoid receptor, DNA-response-elements, renocardiovascular system

victor-s-martinResearch Group 2

Head: Professor Victor S Martin

Universidad de La Laguna

Keywords: Synthetic chemistry, New chemotypes for the mineralocorticoid receptor blockage, Library of synthesised small molecules

D Alvarez de la RossaResearch Group 3

Head: Dr. Diego Alvarez de la Rosa

Associate Professor, Department of Physiology and Institute of Biomedical Technology.

University of Laguna, Spain

Keywords: Post-translational modifications, ion channels, electrophysiology, whole animal physiology

 

brian_harveyResearch Group 4

Head: Professor Brian Harvey

Director, Molecular Medicine Research Laboratories

Royal College of Surgeons in Ireland (RCSI), Beaumont Hospital, Dublin, Ireland

Keywords:  Epithelial Na+ channel (ENaC), estrogen, ion channels, kidney, intestine

 

rosariogonzalez

Research Group 5

Head: Professor Rosario González Muñiz

Research Scientist at the Medicinal Chemistry Institute (IQM-CSIC), Madrid, Spain

Keywords:  Medicinal chemistry, antagonists for bioactive peptides, modulators of ionchannels, non-steroid MR ligands

 

A key outcome will be a deeper knowledge of the molecular MR-structure-function-relationship from exploring the influence of MR subdomains and modifications for mediating or modulating (i) classical genomic MR functions, (ii) novel genomic MR effects and (iii) non-genomic MR-protein interactions.

The mineralocorticoid receptor MR is a ligand-dependent transcription factor without a strictly MR-specific hormone-response-element and with partially promiscuous ligands. Nevertheless, the MR elicits specific effects of physiological and pathological relevance in different tissues which will be characterized in detail in WGs 3-6. This WG aims to characterize the importance and consequences of different receptor domains and post-transcriptional modifications for MR function in detail. Using  innovative screening approaches including ChIP-Seq experiments for identifying new MR target genes, advanced fluorescent imaging techniques for investigating protein-protein interactions and to determine subcellular spatiotemporal trafficking patterns as well as peptide arrays for investigating post-translational modifications we plan to

    • Untangling the mechanism and impact of compartmentalized MR signaling at the plasma membrane and in the cytosol, ER and nucleus.

 

    • Characterizing the influence of post-translational modifications on MR function and stability

 

    • Assessing the effect of interaction with tissue specific co-regulators.

 

    • Exploration of MR domains responsible for protein-protein interactions and the corresponding signaling partners as well as the spatiotemporal organization and functional consequences of these interactions.

A set of fully functional fluorescent MR mutants is available to manifest the interaction between MR structure and function. Individual interactions will be characterized by a wide range of state-of-the-art molecular biology, protein biochemistry and cell biology methods including sophisticated approaches such as FRET and BRET. Read-out parameters for MR function include DNA-binding tests (ChIP), MR transactivation hormone-response-element-reporter-gene assays, non-genomic mitogen activated kinase phosphorylation assays and co-immunoprecipitation/co-localization experiments. A variety of tagged MR-plasmids and also MR-specific antibodies for the different applications already exist.